NEOVASC INC | CIK:0001399708 | 3

  • Filed: 5/16/2018
  • Entity registrant name: NEOVASC INC (CIK: 0001399708)
  • Generator: Merrill
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1399708/000104746918003806/0001047469-18-003806-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1399708/000104746918003806/nvcn-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001399708
  • Open this page in separate window: Click
  • ifrs-full:DisclosureOfExpensesByNatureExplanatory

                                                                                                                                                                                                                            

     

     

     

    For the years ended December 31,

     

     

     

     

    2017

     

    2016

     

    2015

     

     

    COST OF GOODS SOLD

     

     

     

     

     

     

     

     

     

     

     

    Depreciation

     

    $

    59,115

     

    $

    209,613

     

    $

    165,884

     

     

    Share-based payments

     

     

    70,242

     

     

    45,803

     

     

    310,360

     

     

    Cash-based employee expenses

     

     

    2,595,654

     

     

    2,753,841

     

     

    3,070,566

     

     

    Other expenses

     

     

    752,810

     

     

    4,082,504

     

     

    3,391,324

     

     

     

     

     

     

     

     

     

     

     

     

     

    $

    3,477,821

     

    $

    7,091,761

     

    $

    6,938,134

     

     

     

     

     

     

     

     

     

     

     

    EXPENSES

     

     

     

     

     

     

     

     

     

     

     

    Selling expenses

     

     

     

     

     

     

     

     

     

     

     

    Share-based payments

     

    $

    98,379

     

    $

    138,334

     

    $

    120,780

     

     

    Cash-based employee expenses

     

     

    202,261

     

     

    109,150

     

     

    31,447

     

     

    Other expenses

     

     

    585,586

     

     

    449,154

     

     

    503,442

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    886,226

     

     

    696,638

     

     

    655,669

     

     

     

     

     

     

     

     

     

     

     

    General and administrative expenses

     

     

     

     

     

     

     

     

     

     

     

    Depreciation

     

     

    93,196

     

     

    119,977

     

     

    78,544

     

     

    Share-based payments

     

     

    1,080,627

     

     

    510,508

     

     

    1,323,583

     

     

    Cash-based employee expenses

     

     

    2,792,897

     

     

    2,713,110

     

     

    2,128,392

     

     

    Litigation expenses

     

     

    2,410,350

     

     

    13,170,138

     

     

    7,058,226

     

     

    Expenses related to the financing

     

     

    5,447,182

     

     

     

     

     

     

    Other expenses

     

     

    3,860,531

     

     

    2,669,054

     

     

    3,324,331

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    15,684,783

     

     

    19,182,787

     

     

    13,913,076

     

     

     

     

     

     

     

     

     

     

     

    Product development and clinical trials expenses

     

     

     

     

     

     

     

     

     

     

     

    Depreciation

     

     

    382,234

     

     

    426,144

     

     

    259,281

     

     

    Share-based payments

     

     

    1,235,294

     

     

    1,115,466

     

     

    2,359,442

     

     

    Cash-based employee expenses

     

     

    4,971,668

     

     

    6,183,013

     

     

    5,000,258

     

     

    Other expenses

     

     

    10,899,896

     

     

    11,639,880

     

     

    9,562,414

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    17,489,092

     

     

    19,364,503

     

     

    17,181,395

     

     

     

     

     

     

     

     

     

     

     

    TOTAL EXPENSES

     

    $

    34,060,101

     

    $

    39,243,928

     

    $

    31,750,140

     

     

     

     

     

     

     

     

     

     

     

    Depreciation per Statements of Cash Flows

     

    $

    534,545

     

    $

    755,734

     

    $

    503,709

     

     

     

     

     

     

     

     

     

     

     

    Share-based payments per Statements of Cash Flows

     

    $

    2,484,542

     

    $

    1,810,111

     

    $

    4,114,165

     

     

     

     

     

     

     

     

     

     

     

    Cash-based employee expenses (see Note 19)

     

    $

    10,562,480

     

    $

    11,759,114

     

    $

    10,230,663